Epiprobe

奕谱生物

Epiprobe

Biotech/Healthcare

Founded in 2018, Yipu Bio positions itself as an advocate and pioneer of pan-cancer early screening and is a high-tech enterprise focused on molecular cancer diagnostics and the precision medicine industry. Building on its core team's long-term work in DNA methylation research and translation, and…

Latest round: Series B (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-04-01